Evidence map›Paper›PMID 27405757›Full record

ArticleThe Journal of biological chemistry2016

Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66.

Amit Gupta, Nicholas R Leslie

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Precise Immunodetection of PTEN Protein in Human Neoplasia.Cold Spring Harbor perspectives in medicine · 2019
    Review
  5. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  6. Regulation and modulation of PTEN activity.Molecular biology reports · 2018
    Review
  7. Article
  8. Review
  9. Article
  10. Importin-11 keeps PTEN safe from harm.The Journal of cell biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amit GuptaFrom the Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, James Nasmyth Building, Riccarton Campus, Edinburgh EH14 4AS, United Kingdom amit.gupta@icr.ac.uk.
Nicholas R LeslieFrom the Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot Watt University, James Nasmyth Building, Riccarton Campus, Edinburgh EH14 4AS, United Kingdom n.r.leslie@hw.ac.uk.ORCID 0000-0001-5131-0541
Heriot-Watt University · GB

Funding

Medical Research Council G0801865Medical Research Council G0801865/2Medical Research Council G9403619
6 · The paper itself

Abstract

Phosphatase and tensin homolog (PTEN) is a phosphoinositide lipid phosphatase and one of the most frequently disrupted tumor suppressors in many forms of cancer, with even small reductions in the expression levels of PTEN promoting cancer development. Although the post-translational ubiquitination of PTEN can control its stability, activity, and localization, a detailed understanding of how PTEN ubiquitination integrates with other cellular regulatory processes and may be dysregulated in cancer has been hampered by a poor understanding of the significance of ubiquitination at individual sites. Here we show that Lys(66) is not required for cellular activity, yet dominates over other PTEN ubiquitination sites in the regulation of protein stability. Notably, combined mutation of other sites (Lys(13), Lys(80), and Lys(289)) has relatively little effect on protein expression, protein stability, or PTEN polyubiquitination. The present work identifies a key role for Lys(66) in the regulation of PTEN expression and provides both an opportunity to improve the stability of PTEN as a protein therapy and a mechanistic basis for efforts to stabilize endogenous PTEN.

Indexed as

Cell Line, TumorEnzyme StabilityHEK293 CellsHumansLysinePTEN PhosphohydrolaseUbiquitinationLysinePTEN PhosphohydrolasePTEN protein, humancancerphosphatasephosphatase and tensin homolog (PTEN)phosphoinositidephosphoinositide 3-kinaseprotein stabilitytumor suppressorubiquitylation (ubiquitination)

Identifiers

PMID27405757
PMCPMC5000091
OpenAlexW2469843518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.